SECOND SIGHT MED PRODS INC - COM NEW (EYES)

CUSIP: 81362J209

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / COM NEW
Total 13F shares
2,737,149
Share change
-842,076
Total reported value
$3,911,000
Put/Call ratio
58%
Price per share
$1.43
Number of holders
22
Value change
-$1,323,286
Number of buys
10
Number of sells
15

Quarterly Holders Quick Answers

What is CUSIP 81362J209?
CUSIP 81362J209 identifies EYES - SECOND SIGHT MED PRODS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SECOND SIGHT MED PRODS INC - COM NEW (EYES) as of Q1 2022

As of 31 Mar 2022, SECOND SIGHT MED PRODS INC - COM NEW (EYES) was held by 22 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,737,149 shares. The largest 10 holders included VANGUARD GROUP INC, MORGAN STANLEY, GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, BlackRock Inc., NORTHERN TRUST CORP, GOLDMAN SACHS GROUP INC, and CITADEL ADVISORS LLC. This page lists 22 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.